Calcium-dependent protease modulation with selective calpain inhibitors — the intracellular cysteine proteases (calpain-1, calpain-2, calpain-3, tissue-specific isoforms) implicated in neurodegeneration, muscular dystrophy, ischemic injury, and cancer progression representing the fastest-advancing segment in protease-targeted drug development — creates the most mechanistically...